Source: Molecular Psychiatry. Unidade: IB
Subjects: AUTISMO, DOENÇAS GENÉTICAS
ABNT
SUZUKI, A. M. et al. Altered mTORC1 signaling in multipotent stem cells from nearly 25% of patients with nonsyndromic autism spectrum disorders [Letter to the Editor]. Molecular Psychiatry. London: Instituto de Biociências, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/mp.2014.175. Acesso em: 18 nov. 2024. , 2015APA
Suzuki, A. M., Griesi-Oliveira, K., Machado, C. de O. F., Vadasz, E., Zachi, E. C., Passos-Bueno, M. R., & Sertie, A. L. (2015). Altered mTORC1 signaling in multipotent stem cells from nearly 25% of patients with nonsyndromic autism spectrum disorders [Letter to the Editor]. Molecular Psychiatry. London: Instituto de Biociências, Universidade de São Paulo. doi:10.1038/mp.2014.175NLM
Suzuki AM, Griesi-Oliveira K, Machado C de OF, Vadasz E, Zachi EC, Passos-Bueno MR, Sertie AL. Altered mTORC1 signaling in multipotent stem cells from nearly 25% of patients with nonsyndromic autism spectrum disorders [Letter to the Editor] [Internet]. Molecular Psychiatry. 2015 ;( Ja 2015.): 1-2.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/mp.2014.175Vancouver
Suzuki AM, Griesi-Oliveira K, Machado C de OF, Vadasz E, Zachi EC, Passos-Bueno MR, Sertie AL. Altered mTORC1 signaling in multipotent stem cells from nearly 25% of patients with nonsyndromic autism spectrum disorders [Letter to the Editor] [Internet]. Molecular Psychiatry. 2015 ;( Ja 2015.): 1-2.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/mp.2014.175